Clinical Trials Logo

Clinical Trial Summary

The objective is to compare the ultrasound index fat fraction (FAT PLUS), derived from several ultrasound biomarkers, with the gold-standard imaging exam for liver fat content evaluation (MRI-PDFF) in patients to quantify the hepatic steatosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06373796
Study type Interventional
Source SuperSonic Imagine
Contact
Status Not yet recruiting
Phase N/A
Start date May 2024
Completion date September 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05479721 - LITMUS Imaging Study
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Not yet recruiting NCT05120557 - Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH N/A
Completed NCT03858920 - The Liver in the World Trade Center Health Program General Responder Cohort and Controls
Withdrawn NCT02873507 - Prediction of Donor Liver Adipose Content by Magnetic Resonance Imaging N/A
Recruiting NCT04442334 - The European NAFLD Registry
Not yet recruiting NCT06154096 - Liver Fat and Glucagon Resistance
Not yet recruiting NCT06373536 - Comparison of MRI-PDFF to TAEUS FLIP Device to Estimate Liver Fat Fraction in Adults
Not yet recruiting NCT06453239 - Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD
Enrolling by invitation NCT05676177 - CT Liver Fat Fraction Quantification N/A
Not yet recruiting NCT05651724 - Global Research Initiative for Patients Screening on NASH
Recruiting NCT06021743 - The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis
Completed NCT03203486 - Response of NAFLD Patients to Mediterranean Diet N/A